Dimethyl Itaconate As A Novel Anti-Inflammatory Agent Targeting Tnf-Α-Driven Nf-Κb Activation In Epithelial Cell Models. Rev Diabet Stud. Published online September 10, 2025:1-21. doi:10.1900/q356v768